Total Funding
25
12
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
327444
CAPNIA employs its proprietary medical gas delivery system to develop therapeutic products for chronic diseases.
Steinar Engelsen: Member Of The Board Of DirectorsPast Role: Nycomed Pharma, Senior Vice President, Research & Development- Tony Wondka: SVP & General ManagerPast Role: Breathe Technologies, Vice President
About the Company
CAPNIA is a private company developing novel therapeutic products using its proprietary medical gas delivery system. We are targeting a number of chronic diseases treatable with topical application of well understood, safe and effective gas compounds. Our first product is entering Phase IIb clinical trials for the treatment of acute migraines and
related symptoms. 28 million Americans and over 240 million people worldwide suffer from this debilitating condition.
